199 related articles for article (PubMed ID: 38296283)
1. Self-reported MeasUrement of Physical and PsychosOcial Symptoms Response Tool (SUPPORT-dialysis): systematic symptom assessment and management in patients on in-centre haemodialysis - a parallel arm, non-randomised feasibility pilot study protocol.
Gill JK; Pucci M; Samudio A; Ahmed T; Siddiqui R; Edwards N; Marticorena RM; Donnelly S; Lok C; Wentlandt K; Wolofsky K; Mucsi I
BMJ Open; 2024 Jan; 14(1):e080712. PubMed ID: 38296283
[TBL] [Abstract][Full Text] [Related]
2. Use of an electronic patient-reported outcome measure in the management of patients with advanced chronic kidney disease: the RePROM pilot trial protocol.
Kyte D; Bishop J; Brettell E; Calvert M; Cockwell P; Dutton M; Eddington H; Hadley G; Ives NJ; Jackson LJ; Stringer S; Valente M
BMJ Open; 2018 Oct; 8(10):e026080. PubMed ID: 30373785
[TBL] [Abstract][Full Text] [Related]
3. Results of a pilot feasibility randomised controlled trial exploring the use of an electronic patient-reported outcome measure in the management of UK patients with advanced chronic kidney disease.
Kyte D; Anderson N; Bishop J; Bissell A; Brettell E; Calvert M; Chadburn M; Cockwell P; Dutton M; Eddington H; Forster E; Hadley G; Ives NJ; Jackson LJ; O'Brien S; Price G; Sharpe K; Stringer S; Verdi R; Waters J; Wilcockson A
BMJ Open; 2022 Mar; 12(3):e050610. PubMed ID: 35304391
[TBL] [Abstract][Full Text] [Related]
4. Embedding electronic patient-reported outcome measures into routine care for patients with stage III MELanoma (ePROMs-MEL): protocol for a prospective, longitudinal, mixed-methods pilot study.
Dempsey K; Saw R; Bartula I; Lo S; Lawn C; Pennington T; Spillane A; Boyle F; Dong S; Dieng M; Milne D; Seaman L; Saks D; Lai-Kwon J; Thompson JR; Morton R
BMJ Open; 2022 Dec; 12(12):e066852. PubMed ID: 36600423
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Exercise programme to improve quality of life for patients with end-stage kidney disease receiving haemodialysis: the PEDAL RCT.
Greenwood SA; Koufaki P; Macdonald JH; Bulley C; Bhandari S; Burton JO; Dasgupta I; Farrington K; Ford I; Kalra PA; Kumwenda M; Macdougall IC; Messow CM; Mitra S; Reid C; Smith AC; Taal MW; Thomson PC; Wheeler DC; White C; Yaqoob M; Mercer TH
Health Technol Assess; 2021 Jun; 25(40):1-52. PubMed ID: 34156335
[TBL] [Abstract][Full Text] [Related]
7. Feasibility and acceptability of e-PROMs data capture and feedback among patients receiving haemodialysis in the Symptom monitoring WIth Feedback Trial (SWIFT) pilot: protocol for a qualitative study in Australia.
Duncanson E; Bennett PN; Viecelli A; Dansie K; Handke W; Tong A; Palmer S; Jesudason S; McDonald SP; Morton RL;
BMJ Open; 2020 Nov; 10(11):e039014. PubMed ID: 33158824
[TBL] [Abstract][Full Text] [Related]
8. Improving the patient-centred care of children with life-altering skin conditions using feedback from electronic patient-reported outcome measures: protocol for a hybrid effectiveness-implementation study (PEDS-ePROM).
Tyack Z; Simons M; McPhail SM; Harvey G; Zappala T; Ware RS; Kimble RM
BMJ Open; 2021 Apr; 11(4):e041861. PubMed ID: 33837095
[TBL] [Abstract][Full Text] [Related]
9. Cognitive-behavioural therapy (CBT) for renal fatigue (BReF): a feasibility randomised-controlled trial of CBT for the management of fatigue in haemodialysis (HD) patients.
Picariello F; Moss-Morris R; Macdougall IC; Norton S; Da Silva-Gane M; Farrington K; Clayton H; Chilcot J
BMJ Open; 2018 Mar; 8(3):e020842. PubMed ID: 29523571
[TBL] [Abstract][Full Text] [Related]
10. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.
McEvoy NL; Clarke JL; Mc Elvaney OJ; Mc Elvaney OF; Boland F; Hyland D; Geoghegan P; Donnelly K; Friel O; Cullen A; Collins AM; Fraughen D; Martin-Loeches I; Hennessy M; Laffey JG; Mc Elvaney NG; Curley GF
Trials; 2021 Apr; 22(1):288. PubMed ID: 33874981
[TBL] [Abstract][Full Text] [Related]
11. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
12. The Symptom Monitoring with Feedback Trial (SWIFT): protocol for a registry-based cluster randomised controlled trial in haemodialysis.
Greenham L; Bennett PN; Dansie K; Viecelli AK; Jesudason S; Mister R; Smyth B; Westall P; Herzog S; Brown C; Handke W; Palmer SC; Caskey FJ; Couchoud C; Simes J; McDonald SP; Morton RL
Trials; 2022 May; 23(1):419. PubMed ID: 35590395
[TBL] [Abstract][Full Text] [Related]
13. Integrating Conservative kidney management Options and advance care Planning Education (COPE) into routine CKD care: a protocol for a pilot randomised controlled trial.
Stallings TL; Temel JS; Klaiman TA; Paasche-Orlow MK; Alegria M; O'Hare A; O'Connor N; Dember LM; Halpern SD; Eneanya ND
BMJ Open; 2021 Feb; 11(2):e042620. PubMed ID: 33619188
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of a brief positive skills intervention to improve psychological adjustment in patients with end-stage kidney disease newly initiated on haemodialysis: protocol for a randomised controlled trial (HED-Start).
Griva K; Chia JMX; Goh ZZS; Wong YP; Loei J; Thach TQ; Chua WB; Khan BA
BMJ Open; 2021 Sep; 11(9):e053588. PubMed ID: 34548369
[TBL] [Abstract][Full Text] [Related]
15. CovEMERALD: Assessing the feasibility and preliminary effectiveness of remotely delivered Eye Movement Desensitisation and Reprocessing following Covid-19 related critical illness: A structured summary of a study protocol for a randomised controlled trial.
Bates A; Rushbrook S; Shapiro E; Grocott M; Cusack R
Trials; 2020 Nov; 21(1):929. PubMed ID: 33203440
[TBL] [Abstract][Full Text] [Related]
16. Protocol for a pilot randomised controlled trial of an educational programme for adults on chronic haemodialysis with fatigue (Fatigue-HD).
Farragher JF; Thomas C; Ravani P; Manns B; Elliott MJ; Hemmelgarn BR
BMJ Open; 2019 Jul; 9(7):e030333. PubMed ID: 31366664
[TBL] [Abstract][Full Text] [Related]
17. Carer administration of as-needed subcutaneous medication for breakthrough symptoms in people dying at home: the CARiAD feasibility RCT.
Poolman M; Roberts J; Wright S; Hendry A; Goulden N; Holmes EA; Byrne A; Perkins P; Hoare Z; Nelson A; Hiscock J; Hughes D; O'Connor J; Foster B; Reymond L; Healy S; Lewis P; Wee B; Johnstone R; Roberts R; Parkinson A; Roberts S; Wilkinson C
Health Technol Assess; 2020 May; 24(25):1-150. PubMed ID: 32484432
[TBL] [Abstract][Full Text] [Related]
18. ACCESS HD pilot: A randomised feasibility trial Comparing Catheters with fistulas in Elderly patientS Starting haemodialysis.
Quinn R; Ravani P;
BMJ Open; 2016 Nov; 6(11):e013081. PubMed ID: 27884849
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of Symptom monitoring WIth Feedback Trial (SWIFT) for adults on hemodialysis: a registry-based cluster randomized pilot trial.
Agarwal N; Shah KK; Dansie K; Bennett PN; Greenham L; Brown C; Smyth B; McDonald S; Jesudason S; Viecelli AK; Morton RL;
BMC Nephrol; 2023 Nov; 24(1):345. PubMed ID: 37993776
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
